1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) News

TEVA

Teva Pharmaceutical Industries Ltd

7,4701
0,1401 (1,91%)
Upgrade auf Real-Time
Name Symbol Markt Aktientyp
Teva Pharmaceutical Industries Ltd TEVA NYSE Depository Receipt
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,1401 1,91% 7,4701 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
7,45 7,33 7,50 7,45 7,33
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.5.202322:29EDGARSpecialized Disclosure Report (sd)
24.5.202322:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
20.5.202317:00BWTeva to Present Data Demonstrating UZEDY™ (risperidone)..
18.5.202314:30BWTeva Launches New “Pivot to Growth” Strategy
15.5.202314:00BWAUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New..
11.5.202322:01EDGARCurrent Report Filing (8-k)
10.5.202322:05EDGARQuarterly Report (10-q)
10.5.202313:00BWTeva Reports First Quarter 2023 Financial Results and..
09.5.202313:00BWTeva Shares Progress Toward Access to Medicines and..
03.5.202314:30BWU.S. Mental Health Access Program Expands Medicine Donation..
29.4.202302:22BWTeva and MedinCell Announce FDA Approval of UZEDY™..
29.4.202301:22BWTeva and MedinCell Announce FDA Approval of UZEDY™..
27.4.202314:35BWTeva to Launch New Growth Strategy at Investor Day
19.4.202322:18EDGARAnnual Report to Security Holders (ars)
19.4.202322:13EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
14.4.202322:15BWTeva to Host Conference Call to Discuss First Quarter 2023..
14.4.202320:28DJNTeva Shares Drop 11% After Alvotech Gets FDA Complete..
14.4.202302:53BWComplete Response Letter Received for AVT02 Biologics..
11.4.202314:00BWTeva to Present New Data on Once-Daily AUSTEDO® XR..
27.3.202314:00BWTeva’s Digital Health Collaboration with Rimidi Expands to..
13.3.202314:33BWTeva Announces Early Tender Results of its Debt Tender..
09.3.202323:19EDGARCurrent Report Filing (8-k)
09.3.202314:00BWTeva and Natco Announce Launch of additional strengths for..
08.3.202322:06EDGARStatement of Changes in Beneficial Ownership (4)
08.3.202322:05EDGARStatement of Changes in Beneficial Ownership (4)
08.3.202322:04EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:14EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:14EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:12EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:11EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:10EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:09EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:07EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:05EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:04EDGARStatement of Changes in Beneficial Ownership (4)
07.3.202322:00BWTeva to Present at the Barclays Global Healthcare Conference
03.3.202313:04EDGARCurrent Report Filing (8-k)
03.3.202313:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
02.3.202313:39EDGARStatement of Changes in Beneficial Ownership (4)
02.3.202313:39EDGARStatement of Changes in Beneficial Ownership (4)
02.3.202313:38EDGARStatement of Changes in Beneficial Ownership (4)
02.3.202313:37EDGARStatement of Changes in Beneficial Ownership (4)
02.3.202313:36EDGARStatement of Changes in Beneficial Ownership (4)
02.3.202313:36EDGARStatement of Changes in Beneficial Ownership (4)
02.3.202313:35EDGARStatement of Changes in Beneficial Ownership (4)
02.3.202313:34EDGARStatement of Changes in Beneficial Ownership (4)
02.3.202313:34EDGARStatement of Changes in Beneficial Ownership (4)
01.3.202322:13EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
01.3.202322:11BWTeva Announces Successful Upsize and Pricing of..
27.2.202309:30BWTeva Announces $2,250,000,000 Debt Tender Offers for Notes..
Kürzlich von Ihnen besucht
NYSE
TEVA
Teva Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Melden Sie sich bei ADVFN an
Jetzt registrieren

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Support: +44 (0) 203 8794 460 | support@advfn.de

V: D: 20230528 23:27:11